clinical trial · NCT07525089
Human Clinical Trial to Evaluate the Decolonization Efficacy of BM111 Against Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococcus (VRE)
VRE ColonizationCRE ColonizationBM111Placebo
brief summary
A clinical study to eliminate intestinal colonization in subjects harboring microorganisms resistant to carbapenem and vancomycin antibiotics, thereby treating infections caused by these microorganisms.
started
Mar 23, 2026
primary completion
Oct 30, 2026
completion
Feb 20, 2027
last updated
Apr 13, 2026
official title
A Stratified, Randomized, Double-Blind, Placebo-Controlled Human Clinical Trial to Evaluate the Decolonization Efficacy of BM111 Against Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococcus (VRE)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol